(ATTN: ADDS plan to bring in Pfizer''s Paxlovid pills in last 3 paras) SEOUL, Feb. 25 (Yonhap) -- South Korea''s daily COVID-19 cases fell below 170,000 on Friday, but critical cases and deaths from the virus rose at a fast pace amid the continued spread
Biohaven Pharmaceutical (BHVN) and Pfizer (PFE) a committee of the European Medicines Agency ((EMA)) recommended the approval of 75 mg dose of rimegepant for the acute treatment…

120 Million Reasons to Buy Pfizer Stock on the Dip

10:52am, Friday, 25'th Feb 2022 The Motley Fool
COVID-19 pill Paxlovid is poised to be a huge growth driver for the big drugmaker.

Canada clears world''s first plant-based vaccine against Covid-19

04:36am, Friday, 25'th Feb 2022 Business Standard
The approval gives people who are hesitant to take currently available vaccines made by Pfizer Inc., AstraZeneca Plc and Moderna Inc. another option.
Covid-19 vaccine: The approval gives people who are hesitant to take currently available vaccines made by Pfizer Inc., AstraZeneca Plc and Moderna Inc. another option
After advertising tech firm manager Lukas Ng kept telling his friends he wanted to “catch Covid-19”, one of them wrote a song about it. A line in the lyrics of the song, that friends of the 32-year-old have been circulating among themselves goes: “Let me get Covid, please!”Ng, who has received two shots of the Pfizer vaccine, tested positive on February 14. It felt like it could not come soon enough though. His girlfriend had tested positive earlier and he continued spending time with her as…

EMA backs Pfizer COVID-19 booster for teens, Moderna shot for ages 6-11

07:06pm, Thursday, 24'th Feb 2022 Channel NewsAsia
The European Union''s health regulator on Thursday (Feb 24) backed giving a booster shot of Pfizer and BioNTech''s COVID-19 vaccine to adolescents aged 12 and over, as well as the expanded use of Moderna''s shot in children ages six to 11. The recommendations by the European Medicine Agency''s (EMA) Committee

Pfizer Invests $68.5 Million in New Pharma R&D Facility

05:41pm, Thursday, 24'th Feb 2022 SBWire
New York, NY -- ( SBWIRE ) -- 02/24/2022 -- Gene therapy is a vital field and one generating a wealth of R&D jobs in pharma today. Companies such as Pfizer are keen to capitalize on progress, as this represents the next phase of innovation for patients currently living day-to-day with rare diseases. In order to push forward its progress in gene therapy, Pfizer has now announced the opening of a new clinical manufacturing facility in Durham, NC. It is part of an $800 million investment that the business is making over six years to build three facilities that will support gene therapy research, development and manufacturing at Pfizer. Currently, Pfizer has three late-stage clinical programs for hemophilia A, hemophilia B, and Duchenne muscular dystrophy (DMD) and 12 pre-clinical programs. The new Durham facility will be a key part of the research and development capacity that Pfizer has worldwide, providing another 85,000 square feet of space for progress and innovation. EPM Scientific was established in 2012 and has supported a myriad of organizations in hiring for growth when it comes to R&D jobs in pharma.
An advisory panel of the European Medicines Agency has recommended that Pfizer (PFE) and BioNTech''s (BNTX) COVID-19 vaccine be authorized as a booster to children 12 years and older.

EU watchdog backs Pfizer booster for children over 12

04:00pm, Thursday, 24'th Feb 2022 UrduPoint
The EUs medicines watchdog on Thursday recommended that Pfizer/BioNTechs anti-Covid booster vaccine be approved for children aged 12 and older.The EMAs human medicines committee (CHMP) has recommended that a booster dose of the Covid-19 vaccine Comirnaty may be given where appropriate to adolesc ..

EMA clears Pfizer''s booster for age 12 and over

03:48pm, Thursday, 24'th Feb 2022 Breaking the News 24/7
The European Medicines Agency approved on Thursday Pfizer''s comirnate from the age of 12 years, as published by the health regulator. According to the press release, comirnaty was already license…
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) revealed Wednesd…

4 Companies That Can Benefit From Buying Back More Stock

10:00am, Thursday, 24'th Feb 2022 Barron''s
Pfizer, Nike, Walmart, and Broadcom are among the companies that have built up a war chest of cash and are considered prime buyback candidates.
The global Global Anti Epileptic Drugs market has been deliberately studied in the report with a large focus on the top players and business strategies, geological expansion, market sections, serious scenes, assembly and estimation, and cost structures. Each segment of
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE